Longitudinal changes in DTI‐ALPS and choroid plexus volume relative to CSF biomarkers during lecanemab treatment in mild cognitive impairment: A pilot study (Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026)